CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,592,232 | +22.7% | 205,258 | +0.2% | 0.01% | +20.0% |
| Q2 2023 | $4,556,889 | +99700.5% | 204,804 | -2.8% | 0.01% | -16.7% |
| Q1 2023 | $4,566 | +13.7% | 210,784 | +6.6% | 0.01% | +20.0% |
| Q4 2022 | $4,017 | -99.9% | 197,808 | +0.5% | 0.01% | -37.5% |
| Q3 2022 | $5,045,000 | +13.5% | 196,754 | +5.3% | 0.01% | +33.3% |
| Q2 2022 | $4,444,000 | +8.8% | 186,873 | +3.0% | 0.01% | +20.0% |
| Q1 2022 | $4,086,000 | +15.6% | 181,456 | +1.6% | 0.01% | +25.0% |
| Q4 2021 | $3,536,000 | +0.0% | 178,561 | -0.6% | 0.00% | -20.0% |
| Q3 2021 | $3,535,000 | -26.8% | 179,625 | -18.2% | 0.01% | -16.7% |
| Q2 2021 | $4,831,000 | -9.1% | 219,612 | -1.7% | 0.01% | -14.3% |
| Q1 2021 | $5,316,000 | -6.8% | 223,444 | +2.5% | 0.01% | -12.5% |
| Q4 2020 | $5,701,000 | +50.3% | 217,910 | +0.0% | 0.01% | +33.3% |
| Q3 2020 | $3,792,000 | -6.2% | 217,847 | -9.3% | 0.01% | -14.3% |
| Q2 2020 | $4,041,000 | +33.7% | 240,232 | -5.5% | 0.01% | +16.7% |
| Q1 2020 | $3,022,000 | -0.9% | 254,123 | +0.8% | 0.01% | +20.0% |
| Q4 2019 | $3,049,000 | -7.3% | 252,023 | +8.3% | 0.01% | -16.7% |
| Q3 2019 | $3,290,000 | +26.8% | 232,783 | +0.1% | 0.01% | +20.0% |
| Q2 2019 | $2,594,000 | -3.2% | 232,604 | +1.9% | 0.01% | 0.0% |
| Q1 2019 | $2,679,000 | -13.2% | 228,188 | -1.2% | 0.01% | -28.6% |
| Q4 2018 | $3,086,000 | +19.6% | 230,966 | +25.5% | 0.01% | +40.0% |
| Q3 2018 | $2,580,000 | -10.4% | 184,022 | +0.4% | 0.01% | -16.7% |
| Q2 2018 | $2,881,000 | +2.2% | 183,247 | +6.9% | 0.01% | 0.0% |
| Q1 2018 | $2,820,000 | -7.1% | 171,457 | +2.0% | 0.01% | 0.0% |
| Q4 2017 | $3,035,000 | +75.9% | 168,057 | +88.1% | 0.01% | +50.0% |
| Q3 2017 | $1,725,000 | +66.7% | 89,357 | +1.9% | 0.00% | +100.0% |
| Q2 2017 | $1,035,000 | +30.8% | 87,672 | +21.5% | 0.00% | 0.0% |
| Q1 2017 | $791,000 | +56.3% | 72,178 | +3.6% | 0.00% | +100.0% |
| Q4 2016 | $506,000 | +29.7% | 69,686 | +16.1% | 0.00% | 0.0% |
| Q3 2016 | $390,000 | +25.8% | 60,002 | +5.5% | 0.00% | 0.0% |
| Q2 2016 | $310,000 | +36.6% | 56,863 | +17.0% | 0.00% | 0.0% |
| Q1 2016 | $227,000 | -6.2% | 48,591 | -0.1% | 0.00% | 0.0% |
| Q4 2015 | $242,000 | +46.7% | 48,631 | +11.1% | 0.00% | 0.0% |
| Q3 2015 | $165,000 | -34.3% | 43,776 | +4.7% | 0.00% | 0.0% |
| Q2 2015 | $251,000 | +3.3% | 41,825 | -3.8% | 0.00% | 0.0% |
| Q1 2015 | $243,000 | +143.0% | 43,475 | +30.3% | 0.00% | – |
| Q4 2014 | $100,000 | -10.7% | 33,375 | -20.3% | 0.00% | – |
| Q3 2014 | $112,000 | -4.3% | 41,885 | 0.0% | 0.00% | – |
| Q2 2014 | $117,000 | -38.4% | 41,885 | -3.7% | 0.00% | -100.0% |
| Q1 2014 | $190,000 | +28.4% | 43,505 | -5.6% | 0.00% | – |
| Q4 2013 | $148,000 | +100.0% | 46,105 | -0.4% | 0.00% | – |
| Q3 2013 | $74,000 | -8.6% | 46,305 | -1.0% | 0.00% | – |
| Q2 2013 | $81,000 | – | 46,796 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |